Anzeige
Meldung des Tages: GOLD-AUSBRUCH: Von der PEA zum Milliarden-Potenzial

QuidelOrtho Aktie News

Aktie
WKN:  A3DNGX ISIN:  US2197981051 US-Symbol:  QDEL Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  USA
28,09 $
-2,47 $
-8,08%
23,747 € 23.01.26
Depot/Watchlist
Marktkapitalisierung *
1,68 Mrd. €
Streubesitz
-10,98%
KGV
-
Index-Zuordnung
-

QuidelOrtho News

22.01.26 - PR Newswire
Strengthening the blood supply: Awareness, challenges and donor impact
Strengthening the blood supply: Awareness, challenges and donor impact PR Newswire
21.01.26 - PR Newswire
QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results
QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results PR Newswire
18.12.25 - PR Newswire
Innovating Diagnostics and What's Next
Innovating Diagnostics and What's Next PR Newswire
24.11.25 - PR Newswire
QuidelOrtho To Participate In Upcoming Investor Conferences
QuidelOrtho To Participate In Upcoming Investor Conferences PR Newswire
20.11.25 - PR Newswire
The Power of Prevention: Detecting Diabetes Before It Strikes
The Power of Prevention: Detecting Diabetes Before It Strikes PR Newswire
05.11.25 - PR Newswire
QuidelOrtho Reports Third Quarter 2025 Financial Results
QuidelOrtho Reports Third Quarter 2025 Financial Results PR Newswire
03.11.25 - PR Newswire
QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay
QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay PR Newswire
23.10.25 - PR Newswire
Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics
Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics PR Newswire
22.10.25 - PR Newswire
QuidelOrtho to Report Third Quarter 2025 Financial Results
QuidelOrtho to Report Third Quarter 2025 Financial Results PR Newswire
16.10.25 - PR Newswire
QuidelOrtho Showcases Leadership in Transfusion Medicine at AABB 2025
QuidelOrtho Showcases Leadership in Transfusion Medicine at AABB 2025 PR Newswire
25.09.25 - PR Newswire
Through Shades of Illness: Science Bytes Podcast Discusses Why Testing Matters
Through Shades of Illness: Science Bytes Podcast Discusses Why Testing Matters PR Newswire
22.09.25 - PR Newswire
QuidelOrtho Announces Availability of QUICKVUE™ Influenza + SARS Test for Professional Use
QuidelOrtho Announces Availability of QUICKVUE™ Influenza + SARS Test for Professional Use PR Newswire
28.08.25 - PR Newswire
QuidelOrtho to Participate in the Baird 2025 Global Healthcare Conference
QuidelOrtho to Participate in the Baird 2025 Global Healthcare Conference PR Newswire
21.08.25 - PR Newswire
QuidelOrtho Completes Debt Refinancing
QuidelOrtho Completes Debt Refinancing PR Newswire
21.08.25 - PR Newswire
Science Bytes Podcast Explores How Diagnostics Can Help Protect Students and Communities
Science Bytes Podcast Explores How Diagnostics Can Help Protect Students and Communities PR Newswire
19.08.25 - PR Newswire
QuidelOrtho Welcomes Erich Wolff as Executive Vice President, Strategy & Corporate Development
QuidelOrtho Welcomes Erich Wolff as Executive Vice President, Strategy & Corporate Development PR Newswire
13.08.25 - PR Newswire
QuidelOrtho Launches Certified Analyzer Program
QuidelOrtho Launches Certified Analyzer Program PR Newswire
05.08.25 - PR Newswire
QuidelOrtho Reports Second Quarter 2025 Financial Results
QuidelOrtho Reports Second Quarter 2025 Financial Results PR Newswire
29.07.25 - PR Newswire
QuidelOrtho Recognized with Three Awards in 2025 IMV ServiceTrak™
QuidelOrtho Recognized with Three Awards in 2025 IMV ServiceTrak™ PR Newswire
24.07.25 - PR Newswire
Urgent Need for Early Detection in Drug Overdose Cases Highlighted in New Podcast
Urgent Need for Early Detection in Drug Overdose Cases Highlighted in New Podcast PR Newswire

Newssuche

Videos

newspaper
22.01.26 -5,56%
Trading Insights vom 22.01.26
Preisschock bei Erdgas! Was sind die Gründe, wie geht man damit um? Gold auf neuem Allzeithoch: wie ... Mehr »